Российские ученые разработали вакцину для персонализированной терапии рака легкого
Российские ученые разработали вакцину для персонализированной терапии рака легкого Новости Беларуси | БелТА
Онкология
🎗️Лента новостей
Онкология
Российские ученые разработали вакцину для персонализированной терапии рака легкого
Российские ученые разработали вакцину для персонализированной терапии рака легкого Новости Беларуси | БелТА
🎗️
Онкология
О самом коварном раке врачи сказали честно – пропускаем первый симптом
О самом коварном раке врачи сказали честно – пропускаем первый симптом 19rusinfo.ru
Онкология
FDA OKs Lyrfigtu for previously treated bile duct cancer
The FDA approved lirafugratinib — a kinase inhibitor — for adults with previously treated unresectable, locally advanced or metastatic cholangiocarcinoma. The indication for lirafugratinib (Lyrfigtu, Elevar Therapeutics) applies to patients with a fibroblast growth factor receptor 2 (FGFR2) gene fusion or other…
Онкология
Названы неочевидные симптомы рака крови
Названы неочевидные симптомы рака крови gazeta.press
🎗️
Онкология
Названы неочевидные симптомы рака крови
Названы неочевидные симптомы рака крови gazeta.press
Онкология
Childhood cancer survivors' cells repair low-dose radiation damage more efficiently, study finds
A study of how cells repair radiation-induced genetic damage offers clues to why some people develop cancer early in life or more than once. The findings were recently published in the journal Proceedings of the National Academy of Sciences.
Онкология
Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer
Pancreatic cancer does not respond to most immunotherapies, but RAS inhibitors could alter tumors to make them more sensitive to a novel immunotherapeutic approach. In pancreatic tumors with RAS mutations, RAS inhibitors cause massive cell death and reduce immunosuppression. These changes tend to be temporary because…
Онкология
Fitness Beats Age: What Really Decides Curative Cancer Care in Older Adults
Fitness Beats Age: What Really Decides Curative Cancer Care in Older Adults Bioengineer.org
Онкология
Researchers identify cellular stress-protection system that may help tumors withstand chemotherapy
Many cancer treatments work by exploiting weaknesses in tumor cells, overwhelming their ability to survive, repair damage or continue growing. Yet some cancer cells manage to survive treatment. A new study from Texas A&M University sheds light on one reason why: Some cancer cells have a survival toolkit.
🎗️
Онкология
Defining Clinical Response to Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer - Thomas Flaig & Chiara Mercinelli
Defining Clinical Response to Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer - Thomas Flaig & Chiara Mercinelli UroToday
🎗️
Онкология
Virtual reality could become new treatment tool for cancer pain and anxiety, meta-analysis finds
Virtual reality could become new treatment tool for cancer pain and anxiety, meta-analysis finds Managed Healthcare Executive
🎗️
Онкология
5 Big Cancer Advances Redefining Care and Survival
5 Big Cancer Advances Redefining Care and Survival City of Hope
Онкология
Cancer's 'rogue DNA' relies on two proteins to prevent and repair breaks
Researchers at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues have discovered that a type of rogue DNA found in aggressive cancers has a hidden structural weakness—and that blocking a single repair protein can cause it to fall apart, suggesting a new therapeutic opportunity.